Gunnar Jacobsson
Overview
Explore the profile of Gunnar Jacobsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
442
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nibell O, Bjork J, Nilsson A, Jacobsson G, Inghammar M
Clin Microbiol Infect
. 2024 Dec;
PMID: 39716553
Objectives: In this nationwide cohort study in a Scandinavian setting, we aimed to investigate the magnitude of association between flucloxacillin use and drug-induced liver injury (DILI). Methods: Nationwide cohort study...
2.
Karlsson A, Alarcon L, Pineiro-Iglesias B, Jacobsson G, Skovbjerg S, Moore E, et al.
Microorganisms
. 2024 Aug;
12(8).
PMID: 39203567
is a pathogen known to cause a wide range of infections. To find new targets for identification and to understand host-pathogen interactions, many studies have focused on surface proteins. We...
3.
Karp J, Edman-Waller J, Jacobsson G
Infect Dis (Lond)
. 2024 Jul;
56(12):1049-1056.
PMID: 39023136
Background: Antibiotic treatment is a well-known risk factor for infection (CDI). The time from start of antibiotic exposure to onset of CDI for different antibiotics is sparsely studied. CDI with...
4.
Edman-Waller J, Toepfer M, Karp J, Rizzardi K, Jacobsson G, Werner M
Infect Control Hosp Epidemiol
. 2023 Jun;
44(12):1948-1952.
PMID: 37350244
Objective: We evaluated the performance of an early-warning algorithm, based on ward-specific incidence cutoffs for detecting transmission in hospitals. We also sought to determine the frequency of intrahospital transmission in...
5.
Karp J, Edman-Waller J, Toepfer M, Jacobsson G
Anaerobe
. 2023 May;
81:102738.
PMID: 37217115
Objective: The objectives were to determine the risk factors for recurrent healthcare facility-associated Clostridioides difficile infection (HCF-CDI) in a high CDI incidence, low antibiotic use setting and to determine if...
6.
Carlsson F, Jacobsson G, Lampi E
Health Policy
. 2023 Feb;
130:104733.
PMID: 36791598
Misuse and overuse of antibiotics are common in primary care. Guidelines for prescribing of antibiotics are often not followed We conducted a survey of 120 health centers in western Sweden...
7.
Hess-Wargbaner M, Jacobsson G, Bjork D, Edholm A, Qvarfordt I, Sundvall P, et al.
Lakartidningen
. 2022 Oct;
119.
PMID: 36255276
Optimizing antibiotic use to control the spread of antimicrobial resistance is a global health priority. The Swedish strategic programme against antibiotic resistance (Strama) has for many years supported the rational...
8.
Malmberg S, Khan T, Gunnarsson R, Jacobsson G, Sundvall P
Infect Dis (Lond)
. 2022 Jun;
54(9):677-686.
PMID: 35651319
Background: Vital signs are critical in assessing the severity and prognosis of infections, for example, COVID-19, influenza, sepsis, and pneumonia. This study aimed to evaluate a new method for rapid...
9.
MacKinnon M, McEwen S, Pearl D, Lyytikainen O, Jacobsson G, Collignon P, et al.
Antimicrob Resist Infect Control
. 2021 Sep;
10(1):131.
PMID: 34488891
Background: Escherichia coli is an important pathogen in humans and is the most common cause of bacterial bloodstream infections (BSIs). The objectives of our study were to determine factors associated...
10.
MacKinnon M, McEwen S, Pearl D, Lyytikainen O, Jacobsson G, Collignon P, et al.
BMC Infect Dis
. 2021 Jun;
21(1):606.
PMID: 34172003
Background: Escherichia coli is the most common cause of bloodstream infections (BSIs) and mortality is an important aspect of burden of disease. Using a multinational population-based cohort of E. coli...